Page 12 - Current Report News Today

GAAP Net Earnings of $0.03 FFO Before Special Items of $0.33 Same-Property NOI Growth of 5.7% Driven by the Street Portfolio Street Rent Spreads of 37% ...

Item 2.02. Results of Operations and Financial Condition. On April 29, 2024, in connection with the filing...

XTB S.A. DISCLAIMER This English language translation of the Polish version of Current Report No. 23 dated 29 April...

Item 4.01. Change in Registrants Certifying Accountant. The Audit Committee of the Board of Directors of Vroom, Inc. conducted a selection process to determine the...

Item 4.02 - Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review On April 26, 2024, the Audit Committee of the Board of...

NEW YORK, April 29, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor...

Item 1.01 Entry into a Material Definitive Agreement. On April 26th 2024 Regen Biopharma, Inc. entered into an agreement with Value Quest, Inc. . Pursuant to the Value Quest...

Application Pending to Transfer Shares to OTCQX PLANO, Texas, April 29, 2024 /PRNewswire/ -- Direct Selling Acquisition Corp. today announced that it has received a notice letter from the New...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global sha

NEW YORK, April 28, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc.  . Such investors are advised to contact Danielle Peyton at...